[{"id":"cfd16a88-a21f-4f4a-9eae-003d4305ffa0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05120570","created_at":"2021-11-15T12:53:40.169Z","updated_at":"2024-07-02T16:35:08.491Z","phase":"Phase 1/2","brief_title":"PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation","source_id_and_acronym":"NCT05120570","lead_sponsor":"Masonic Cancer Center, University of Minnesota","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sirolimus • VIC-1911"],"overall_status":"Recruiting","enrollment":" Enrollment 75","initiation":"Initiation: 03/17/2022","start_date":" 03/17/2022","primary_txt":" Primary completion: 03/31/2025","primary_completion_date":" 03/31/2025","study_txt":" Completion: 03/31/2028","study_completion_date":" 03/31/2028","last_update_posted":"2024-04-22"}]